EGFR mutant advanced non-small cell lung cancer

Clinical trials for EGFR mutant advanced non-small cell lung cancer explained in plain language.

Never miss a new study

Get alerted when new EGFR mutant advanced non-small cell lung cancer trials appear

Sign up with your email to follow new studies for EGFR mutant advanced non-small cell lung cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 3 Not yet recruiting 1 Terminated 1

Experimental lung cancer drug trial halted early

Disease control Stopped early

This study tested a new drug called TRX-221 in people with a specific type of advanced lung cancer (EGFR mutant NSCLC) that had stopped responding to standard treatments. The goal was to see if the drug was safe and could shrink tumors. The trial was stopped early, and only 19 pe…

Matched conditions: EGFR MUTANT ADVANCED NON-SMALL CELL LUNG CANCER

Phase 1/2 • Sponsor: Therapex Co., Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

EGFR mutant advanced non-small cell lung cancer

Get alerted when new EGFR mutant advanced non-small cell lung cancer trials appear

Experimental lung cancer drug trial halted early